Cardiovascular system in Children with Cystic fibrosis

Completed

• Conditions: 10028593; CF or mucoviscidosis; Cystic Fibrosis; 10010613

• Registration Number: NL-OMON37600
• Lead Sponsor: niversitair Medisch Centrum Utrecht

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 70

Inclusion Criteria

Children with cystic fibrosis:
• Aged 3-12 years
• Who visit the pediatric pulmonology department for their regular control visit;Health controls
• Aged 3-12 year
• Participating in the WHISTLER study

Exclusion Criteria

Children with cystic fibrosis:
• Children with a history of a heart defect will be excluded from this study.;Healthy controls
• Children with a history of a heart defect will be excluded from this study.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameters are the echocardiographic measurements of the<br /><br>cardiovascular system (diastolic function of the right and left ventricle).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secundary study outcome is arterial stiffness (pulse wave velocity) and the<br /><br>respiratory system (the lung function measurement).</p><br>